164 related articles for article (PubMed ID: 7876896)
21. Kinetic mechanism for the interaction of Hirulog with thrombin.
Parry MA; Maraganore JM; Stone SR
Biochemistry; 1994 Dec; 33(49):14807-14. PubMed ID: 7993908
[TBL] [Abstract][Full Text] [Related]
22. Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin.
Lau WF; Tabernero L; Sack JS; Iwanowicz EJ
Bioorg Med Chem; 1995 Aug; 3(8):1039-48. PubMed ID: 7582978
[TBL] [Abstract][Full Text] [Related]
23. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
24. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
Yue SY; Konishi Y
Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.
Chen Z; Li Y; Mulichak AM; Lewis SD; Shafer JA
Arch Biochem Biophys; 1995 Sep; 322(1):198-203. PubMed ID: 7574675
[TBL] [Abstract][Full Text] [Related]
26. Refined structure of the hirudin-thrombin complex.
Rydel TJ; Tulinsky A; Bode W; Huber R
J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
28. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
29. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
[TBL] [Abstract][Full Text] [Related]
30. Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain.
Szyperski T; Güntert P; Stone SR; Wüthrich K
J Mol Biol; 1992 Dec; 228(4):1193-205. PubMed ID: 1335515
[TBL] [Abstract][Full Text] [Related]
31. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
[TBL] [Abstract][Full Text] [Related]
32. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
[TBL] [Abstract][Full Text] [Related]
33. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
DiMaio J; Ni F; Gibbs B; Konishi Y
FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
[TBL] [Abstract][Full Text] [Related]
34. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
Shabareesh P; Kaur KJ
Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
36. Mapping of the thrombin des-ETW conformation by using site-directed mutants of hirudin. Evidence for the induction of nonlocal modifications by mutagenesis.
Le Bonniec BF; Betz A; Guinto ER; Esmon CT; Stone SR
Biochemistry; 1994 Apr; 33(13):3959-66. PubMed ID: 8142400
[TBL] [Abstract][Full Text] [Related]
37. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
Krstenansky JL; Mao SJ
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
[TBL] [Abstract][Full Text] [Related]
38. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
[TBL] [Abstract][Full Text] [Related]
39. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]